DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Pharmathen SA
03 5Accord healthcare
04 1Activo Health
05 1Akorn Pharmaceuticals
06 1Altan Pharma
07 1Aurobindo Pharma Limited
08 1Austell Laboratories
09 2Avet Pharmaceuticals
10 2Avyxa
11 1Baxter Healthcare Corporation
12 1Biem Ilac San. ve Tic. A.S
13 2Biomab Innovation (Pty) Ltd
14 1Chartwell Pharmaceuticals llc
15 1Cipla
16 2Dr Reddy's Laboratories (Australia) Pty Ltd
17 4Farbe Firma
18 1Farmatek
19 4Fresenius Kabi AB Brunna
20 3Fresenius Kabi USA
21 1Fresenius SE & Co. KGaA
22 2Hangzhou Jiuyuan Gene Engineering
23 18Helsinn Advanced Synthesis
24 5Helsinn Birex Pharmaceuticals Lt
25 1Hetero Drugs
26 1Hikma Pharmaceuticals
27 2Hospira, Inc.
28 1Jiangsu Hengrui Medicine
29 1Kalcex
30 2Knight Therapeutics
31 1LABORATORIO REIG JOFRE SA
32 1MEDOCHEMIE LTD
33 1Macleods Pharmaceuticals Limited
34 1Macure Pharma
35 2Medsurge Healthcare
36 1Meitheal Pharmaceuticals
37 1Novast Laboratories
38 1ORIFARM GROUP AS
39 1Pharmada Pharmaceuticals
40 1Polifarma
41 4Qilu Pharmaceutical
42 1Reig Jofre
43 1STADA Arzneimittel
44 2Sagent Pharmaceuticals
45 3Samyang Biopharmaceuticals
46 1Sandoz B2B
47 1Tecnimede
48 3Teva Pharmaceutical Industries
49 2Themis Medicare
50 2TherDose Pharma
51 1Viatris
52 1Yangtze River Pharmaceutical Group
01 1CAPSULE
02 2CAPSULE;ORAL
03 5Capsule
04 1Capsules
05 2Concentrate For Solution For Infusion
06 2Hard Capsule
07 1Hard Capsules
08 8INJ
09 1INJECTABLE;INJECTION
10 25INJECTABLE;INTRAVENOUS
11 1IV Injection Solution
12 2Injectable
13 9Injectable Solution
14 1Injectable Solution In Pre-Filled Syringe
15 12Injection
16 6Injection Solution
17 3Liquid Injection
18 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use
19 1POWDER;INTRAVENOUS
20 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use
21 3Powder For Concentrate For Solution For Infusion
22 1SOLUTION
23 5SOLUTION;INTRAVENOUS
24 1Soft Capsule
25 4Solution For Injection
26 1Solution for I.V. Injection
27 1Solution for IV Injection
28 1Solution for Injection
29 4Blank
01 3Approved
02 8Authorized
03 3Cancelled
04 14DISCN
05 7Generic
06 5Marketed
07 3Not Marketed
08 2Originator
09 12Prescription
10 19RX
11 1USA
12 29Blank
01 4AKYNZEO
02 4ALOXI
03 12Akynzeo
04 7Aloxi
05 1Bevativa
06 1Ferant
07 1Hetnoset
08 1Kemoprev IV
09 1Onicit
10 2PALIBOUT
11 3PALONOSETRON
12 1PALONOSETRON 0.05mg/ml FRESENIUS
13 1PALONOSETRON 0.25 TEVA
14 26PALONOSETRON HYDROCHLORIDE
15 2PALONOSETRON Medsurge
16 2POSFREA
17 1Palcita
18 2Palonosetron
19 2Palonosetron Accord
20 1Palonosetron Altan
21 2Palonosetron Dr.Reddy's
22 4Palonosetron Fresenius Kabi
23 1Palonosetron Kalceks
24 1Palonosetron Qilu
25 1Palonosetron Sala
26 1Palonosetron "Accord"
27 1Palonosetron "Macure"
28 1Palonosetron "Reig Jofre"
29 1Palonosetron "Stada"
30 1Palonosetronhydrochlorid "Qilu"
31 1Paloxitron
32 1Palton
33 1Themiset 250
34 1Themiset 75
35 1Votron
36 12Blank
01 4Australia
02 2Canada
03 4China
04 10Denmark
05 1Greece
06 10India
07 2Italy
08 8Norway
09 1Portugal
10 9South Africa
11 3South Korea
12 11Spain
13 3Sweden
14 4Turkey
15 34USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : DISCN
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300; 0.5
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palonosetron
Dosage Form : Injectable
Dosage Strength : 0.075 mg / 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palonosetron
Dosage Form : Injectable
Dosage Strength : 0.25 mg / 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-03-15
Application Number : 204615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 0.25MG(BASE)/5ML
Packaging :
Approval Date :
Application Number : 204731
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-11-06
Application Number : 204702
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-07-25
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-29
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-22
Application Number : 22233
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 205648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 204289
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2015-10-13
Application Number : 202521
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : DISCN
Registration Country : USA
